Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999

Circulation

Volumn 110, Issue 10, 2004, Pages 1236-1244

  Critchley, Julia ^a   Liu, Jing ^b   Zhao, Dong ^b   Wei, Wang ^b   Capewell, Simon ^c  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b BEIJING INSTITUTE OF HEART   (China)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Coronary disease; Mortality; Prevention; Risk factors

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHINA; CHOLESTEROL BLOOD LEVEL; DEVELOPING COUNTRY; DIABETES MELLITUS; DIET; FEMALE; GENDER; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; POPULATION SIZE; PRIORITY JOURNAL; SECONDARY PREVENTION; SMOKING; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ASPIRIN; CARDIOVASCULAR AGENTS; CHINA; CORONARY DISEASE; DEVELOPING COUNTRIES; DIABETES MELLITUS; DIET; DRUG UTILIZATION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MORTALITY; OBESITY; RISK FACTORS; SMOKING;

EID: 4444347411     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000140668.91896.AE     Document Type: Article

References (62)

1. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E. Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10 year results from 37 WHO MONICA Project populations. Lancet. 1999;353:1547-1557.
2. Beaglehole R. Global cardiovascular disease prevention: time to get serious. Lancet. 2001;358:661-663.
3. Murray C, Lopez A. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269-1276.
4. World Bank. Annual Report. New York, NY: 2001.
5. Zhao SP, Mao JW, Hu JP. The analysis of population mortality rate and causes of death in urban and rural areas of China. Chin J Health Stat. 1999;16:276-280.
6. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596-601.
7. Zhao D, Wu ZS, Wang W, Yao L, Zhou MR. Sino-MONICA: the trend of incidence rate of acute coronary events from 1985 to 1997 in Beijing area. Chin J Cardiol. 2000;27:14-17.
8. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290:86-105.
9. Ebrahim S, Davey-Smith G. Exporting failure? Coronary heart disease and stroke in developing countries. Int J Epidemiol. 2001;30:201-205.
10. Liu B-Q, Peto R, Chen Z-M, Boreham J, Wu Y-P, Li J-Y, Campbell TC, Chen JS. Emerging tobacco hazards in China: 1: retrospective proportional mortality study of one million deaths. BMJ. 1998;317:1411-1422.
11. Niu S-R, Yang G-H, Chen Z-M, Wang J-L, Wang G-H, He X-Z, Schoepff H, Boreham J, Pan HC, Peto R. Emerging tobacco hazards in China: 2: early mortality results from a prospective study. BMJ. 1998;317:1423-1424.
12. Kuulasmaa K, Tunstall PH, Dobson AJ, France M, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project. Lancet. 2000;355:675-687.
13. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ. 1991;303:276-282.
14. Tunstall PH, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations: Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353:1547-1557.
15. Okayama A, Ueshima H, Marmot M, Nakamura M, Kita Y, Yamakawa M. Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan 1980-1989. Int J Epidemiol. 1993;22:1038-1047.
16. Dwyer T, Emmanuel SC, Janus ED, Wu Z, Hynes KL, Zhang C. The emergence of coronary heart disease in population of Chinese descent. Atherosclerosis. 2003;167:303-310.
17. Wu ZS, Yao CH, Zhao D, Wu GX, Wang W, Liu J, Zeng Z, Wu Y. Sino-MONICA Project: a collaborative study on trends and determinants in cardiovascular diseases in China: part I: morbidity and mortality monitoring. Circulation. 2001;103:462-468.
18. Liu J, Zhao D, Qin LP, Wang W, Wu GX, Zeng ZC, Wang WH, Wu ZS. Association of low density lipoprotein cholesterol with cardiovascular disease in a prospective study. Chin J Cardiol. 2001;29:261-265.
19. Zhao D, Wu ZS, Wang W, Liu J, Wu GX, Zeng ZC, Wang WH, Qin LP, Liu S. Association between blood pressure level and risk of cardiovascular diseases in Chinese: a cohort study in 11 provinces of China. Chin J Cardiol. 2001;29:612-617.
20. Critchley JA, Capewell S. Why model coronary heart disease? Eur Heart J. 2002;23:110-116.
21. Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987;77:1417-1426.
22. Gunning-Schepers LJ. Introduction to the Biomed project. In: Public Health Models, Tools for Health Policy Making at National and European Level. Brussels, Belgium: European Commission; 2000.
23. Goldman L, Cook E. The decline in ischemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101:825-836.
24. Beaglehole R. Medical management and the decline in mortality from coronary heart disease. Br Med J Clin Res Ed. 1986;292:33-35.
25. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, Tsevat J, Weinstein MC. The recent decline in mortality from coronary heart disease, 1980-1990: the effect of secular trends in risk factors and treatment. JAMA. 1997;277:535-542.
26. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999;81:380-386.
27. Capewell S, Beaglehole R, Seddon M, McMurray J. Explaining the decline in coronary heart disease mortality in Auckland, New Zealand between 1982 and 1993. Circulation. 2000;102:1151-1156.
28. Unal B, Critchley J, Capewell S, McMurray J. Explaining the decline in CHD mortality in England and Wales, 1981-2000. Circulation. 2004;109:1101-1107.
29. China Statistics. Available at: http://www.bjstats.gov.cn/tslm/sjbjrk/ rkml/index.htm. Accessed August 18, 2004.
30. Wu ZS, Yao CH, Zhao D. Sino-MONICA: II: the results of survey for risk factors of cardiovascular disease. Chin J Cardiol. 1997;25:255-259.
31. Liu J, Zhao D, Yao CH, Wu GX, Wang W, Zeng ZC, Wu ZS. Trends in CVD risk factors in urban and rural areas of Beijing during 1984-1993. Chin J Cardiol. 2000;28:308-311.
32. Wang SR, Liu HX, Zhao D, Lei Y, Fang YT, Hu JX, Shi ZX, Jia HZ, Jiang BQ, Gao GD, Shi XY, Lu WX, Li QL. Survey on the treatment of 1,242 in-hospital AMI in Beijing area. Scientific Theses Compilation of the 6th National Symposium on the Combination of Traditional Chinese Medicine and the Western Medicine. Beijing, China, September 20-23, 2002. Page 33-42.
33. Han ZH, Hu R, Kang JP, Wang J, Wu XS. Comparison of the condition and treatment of heart failure patients between 1990 and 2000 in Beijing Anzhen Hospital. Chin J Geriatr Cardiovasc Cerebrovasc Dis. 2002;4:236-238.
34. Zhou DJ, Ye P, Wei H. Survey of statin therapy in elderly in-patients with unstable angina pectoris. Chin J Geriatr Cardiovasc Cerebrovasc Dis. 2001;3:85-86.
35. Mant J, Hicks N. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ. 1995;311:793-796.
36. Critchley J, Capewell S. Substantial potential for reductions in UK coronary heart disease deaths. J Epidemiol Commun Health. 2003;57:243-247.
37. Critchley JA, Capewell S, Uhal B. Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment? J Clin Epidemiol. 2003;56:583-590.
38. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:367-372.
39. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ. 2002;324:1570-1576.
40. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, for the Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1912.
41. Chen Z-M, Xu Z, Collins R, Li W-X, Peto R. Early health effects of the emerging tobacco epidemic in China. JAMA. 1997;278:1500-1504.
42. Yuan JM, Ross RK, Wang XL, Gao YT, Henderson BE, Yu MC. Morbidity and mortality in relation to cigarette smoking in Shanghai, China: a prospective male cohort study. JAMA. 1996;275:1646-1650.
43. Asia Pacific Studies Collaboration. Cholesterol, coronary heart disease, and stroke in the Asia Pacific Region. Int J Epidemiol. 2003;32:563-572.
44. Nesto R. CHD: a major burden in type 2 diabetes. Acta Diabetol. 2001;38:S3-S8.
45. Keen H, Clark C, Laakso M. Reducing the burden of diabetes: managing cardiovascular disease. Diabetes Metab Res Rev. 1999;15:186-196.
46. Galgali G, Beaglehole R, Scragg R, Tobias M. Potential for prevention of premature death and disease in New Zealand. N Z Med J. 1998;111:7-10.
47. Wu ZS, Yao CH, Zhao D, Wu GX, Wang W, Liu J, Zeng ZC, Wu YK. Sino-MONICA: 1: the results of surveillance for incidence rate and mortality rate. Chin J Cardiol. 1997;25:6-8.
48. MacIntyre K, Capewell S, Stewart S, Chalmers JWT, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000;102:1126-1131.
49. Nichol MB, Venturini F, Sung JC. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother. 1999;33:531-540.
50. National Hypertension Collaborative Survey Group. Report of National Survey on Hypertension from 1979 to 1980. Beijing, China: Chinese Academy of Medical Sciences; 1982:16-19.
51. Briggs A. Economics notes: handling uncertainty in economic evaluation. BMJ. 1999;319:120.
52. Beifan Z. Chinese dietary pattern and features of cardiovascular disease 2002. Presented at: 2nd Five-Continent International Symposium on Cardiovascular Diseases; September 19-22, 2002; Beijing, China.
53. Rose G. Incubation period of coronary heart disease. BMJ. 1982;284:1600-1601.
54. Law M, Wald N. Why heart disease mortality is low in France: the time lag explanation. BMJ. 1999;318:1471-1476.
55. Nolle E, Shkolnikov V, McKee M. Changing mortality patterns in East and West Germany and Poland, II: short-term trends during transition and in the 1990s. J Epidemiol Commun Health. 2000;54:899-906.
56. Rothman K, Greenland S. Causation and causal inference. In Rothman K, Greenland S, eds. Modern Epidemiology. Philadelphia, Pa: Lippincott-Raven; 1998:7-28.
57. The Coordination Group of Pathological Survey. A pathological survey of atherosclerosis of 7159 coronary arteries and 2044 aortae. Chin J Pathol. 1983;12:81-85.
58. National Diabetes Mellitus Collaborative Study Group. Exploring the diagnostic level of fasting plasma glucose in a Chinese diabetic population. Chin J Endocrinol Metab. 1998;14:3-7.
59. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
60. Yang G, Fan L, Tan J, Qi G, Zhang Y, Samet JM, Taylor CE, Becker K, Xu J. Smoking in China: findings of the 1996 National Prevalence Survey. JAMA. 1999;282:1247-1253.
61. Doliszny KM, Luepker RV, Burke GL, Pryor DB, Blackburn H. Estimated contribution of coronary artery bypass graft surgery to the decline in coronary heart disease mortality: the Minnesota Heart Survey. J Am Coll Cardiol. 1994;24:95-103.
62. Wu ZS, Yao CH, Chen DY, Li N, Zhang M, Wu YY, Zhao D, Wu GX, Wu YK. The Sino-MONICA-Beijing study: report on results between 1984-1986. Acta Med Scand 1988;728(suppl):60-66.